WALTHAM, Mass.--(BUSINESS WIRE)--Mar. 8, 2018--
OvaScience℠ (NASDAQ: OVAS), a company focused on the discovery,
development and commercialization of new treatment options for women and
families struggling with infertility, today announced that it will host
a conference call at 4:30 p.m. ET on Thursday, March 15, 2018 to discuss
fourth quarter and fiscal year 2017 financial results and provide a
general corporate update.
The conference call may be accessed by dialing +1-888-424-8151 for U.S.
callers and +1-847-585-4422 for international callers five minutes prior
to the start of the call and providing the passcode 7278292. A live
webcast of the conference call will be available online from the
Investors section of the Company’s website at www.ovascience.com.
A replay of the conference call will be available from 7:00 p.m. ET on
Thursday, March 15, 2018, through 11:59 p.m. ET on Thursday, March 29,
2018, and may be accessed by visiting OvaScience’s website or by dialing
1-888-843-7419 for U.S. callers and 1-630-652-3042 for international
callers. The replay access code is 7278292#.
OvaScience℠, Inc. (NASDAQ:OVAS) is a
fertility company focused on the discovery, development and
commercialization of new treatment options for women and families
struggling with infertility. Each OvaScience treatment is based on the
Company’s proprietary technology platform that leverages the
breakthrough discovery of egg precursor (EggPC℠) cells – immature egg
cells found within the outer ovarian cortex. OvaScience is developing
the OvaPrime℠treatment, which could increase a woman’s egg
reserve and the OvaTure℠ treatment, a potential in vitro fertilization
(IVF) treatment that could help a woman produce new fertilizable eggs
without hormone injections. OvaScience’s AUGMENT℠ treatment, a fertility
option designed to improve IVF success rates, is available in certain
IVF clinics in Canada and Japan. OvaScience treatments are not available
in the United States.
View source version on businesswire.com: http://www.businesswire.com/news/home/20180308005339/en/
Jennifer Viera, 617-420-8748